Publication:
Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: A systematic review

dc.contributor.authorRebecca Lesteren_US
dc.contributor.authorPatrick Musichaen_US
dc.contributor.authorNadja Van Ginnekenen_US
dc.contributor.authorAngela Dramowskien_US
dc.contributor.authorDavidson H. Hameren_US
dc.contributor.authorPaul Garneren_US
dc.contributor.authorNicholas A. Feaseyen_US
dc.contributor.otherMalawi-Liverpool-Wellcome Trust Clinical Research Programmeen_US
dc.contributor.otherLiverpool School of Tropical Medicineen_US
dc.contributor.otherUniversity of Liverpoolen_US
dc.contributor.otherBoston Universityen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.contributor.otherStellenbosch Universityen_US
dc.date.accessioned2020-03-26T04:54:20Z
dc.date.available2020-03-26T04:54:20Z
dc.date.issued2020-03-01en_US
dc.description.abstract© 2020 The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. Background: The prevalence of bacterial bloodstream infections (BSIs) in sub-Saharan Africa (sSA) is high and antimicrobial resistance is likely to increase mortality from these infections. Third-generation cephalosporin-resistant (3GC-R) Enterobacteriaceae are of particular concern, given the widespread reliance on ceftriaxone for management of sepsis in Africa. Objectives: Reviewing studies from sSA, we aimed to describe the prevalence of 3GC resistance in Escherichia coli, Klebsiella and Salmonella BSIs and the in-hospital mortality from 3GC-R BSIs. Methods: We systematically reviewed studies reporting 3GC susceptibility testing of E. coli, Klebsiella and Salmonella BSI. We searched PubMed and Scopus from January 1990 to September 2019 for primary data reporting 3GC susceptibility testing of Enterobacteriaceae associated with BSI in sSA and studies reporting mortality from 3GC-R BSI. 3GC-R was defined as phenotypic resistance to ceftriaxone, cefotaxime or ceftazidime. Outcomes were reported as median prevalence of 3GC resistance for each pathogen. Results: We identified 40 articles, including 7 reporting mortality. Median prevalence of 3GC resistance in E. coli was 18.4% (IQR 10.5 to 35.2) from 20 studies and in Klebsiella spp. was 54.4% (IQR 24.3 to 81.2) from 28 studies. Amongst non-typhoidal salmonellae, 3GC resistance was 1.9% (IQR 0 to 6.1) from 12 studies. A pooled mortality estimate was prohibited by heterogeneity. Conclusions: Levels of 3GC resistance amongst bloodstream Enterobacteriaceae in sSA are high, yet the mortality burden is unknown. The lack of clinical outcome data from drug-resistant infections in Africa represents a major knowledge gap and future work must link laboratory surveillance to clinical data.en_US
dc.identifier.citationJournal of Antimicrobial Chemotherapy. Vol.75, No.3 (2020), 492-507en_US
dc.identifier.doi10.1093/jac/dkz464en_US
dc.identifier.issn14602091en_US
dc.identifier.issn03057453en_US
dc.identifier.other2-s2.0-85079358436en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/53742
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85079358436&origin=inwarden_US
dc.subjectMedicineen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titlePrevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: A systematic reviewen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85079358436&origin=inwarden_US

Files

Collections